Brandywine Global Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

Brandywine Global Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-42,168	Closed	-$911K	–	783
2022 Q4	$911K	Hold	42,168	–	–	0.01%	647
2022 Q3	$816K	Sell	42,168 -1,632	-4%	-$33.8K	0.01%	639
2022 Q2	$870K	Sell	43,800 -6,500	-13%	-$171K	0.01%	621
2022 Q1	$1.5M	Hold	50,300	–	–	0.01%	578
2021 Q4	$1.17M	Buy	+50,300	New	+$1.34M	0.01%	573

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brandywine Global Investment Management's ALBO Position: Q1 2023 in Review

Brandywine Global Investment Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 42,168 shares — an estimated $911K sold.

Brandywine Global Investment Management first reported a position in ALBO in Q4 2021 and held it in 5 quarters. The position peaked at $1.5M in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Brandywine Global Investment Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Brandywine Global Investment Management sold 42,168 Albireo Pharma Inc shares in Q1 2023, an estimated $911K.
Brandywine Global Investment Management first reported a position in Albireo Pharma Inc in Q4 2021 and held it in 5 quarters.
Brandywine Global Investment Management's Albireo Pharma Inc position peaked at $1.5M in Q1 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Brandywine Global Investment Management's 13F filing for Q1 2023, filed 12 May 2023.